Table 4.
17-OHP (N = 327) |
Placebo (N = 330) |
RR (95% CI) | P** | |
---|---|---|---|---|
Gestational age at randomization |
0.20 | |||
< 21 weeks | 21/104 (20.2) | 26/101 (25.7) | 0.78 (0.47 – 1.30) | |
≥21 weeks | 61/223 (27.4) | 54/229 (23.6) | 1.16 (0.85 – 1.59) | |
Cervical length | 0.70 | |||
< 15 mm | 13/25 (52.0) | 17/ 31(54.8) | 0.95 (0.58 – 1.55) | |
≥15 mm | 69/302 (22.8) | 63/299 (21.1) | 1.08 (0.80 – 1.47) | |
Cervical funnel | 0.08 | |||
Absent | 54/239 (22.6) | 50/261 (19.2) | 1.18 (0.84 – 1.66) | |
Present | 28/88 (31.8) | 30/69 (43.5) | 0.73 (0.49 – 1.10) |
Data presented as n/N (%)
P value for Breslow-Day interaction term